Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer.

Autor: Orillard E; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.; EFS, INSERM, UMR RIGHT, Université de Franche-Comté, CHU Besançon, Besançon, France., Adhikari A; Internal Medicine, Ascension Saint Francis Hospital, Evanston, Illinois, USA., Malouf RS; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Calais F; Bibliothèque Universitaire de Santé, Université de Franche-Comté, Besançon, France., Marchal C; SAIC, Université de Franche-Comté, Besançon, France., Westeel V; EFS, INSERM, UMR RIGHT, Université de Franche-Comté, CHU Besançon, Besançon, France.; Department of Chest Diseases and Thoracic Oncology, University Hospital of Besançon, Besançon, France.

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Aug 13; Vol. 8. Cochrane AN: CD015495. Date of Electronic Publication: 2024 Aug 13.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

LBA6 UCPVax therapeutic vaccination promotes cytotoxic and Th1 polarized antitumor CD4 T cells and epitope spreading in patients with advanced non-small cell lung cancer

Autor: Adotevi, O., Laheurte, C., Boullerot, L., Malfroy, M., Richard, T., Cuche, L., Seffar, E., Kaulek, V., Jacquin, M., Orillard, E., Eberst, G., Jandus, C., Westeel, V., Borg, C., Godet, Y.

Publikováno v: In Immuno-Oncology and Technology December 2022 16 Supplement 1

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Autor: Adotévi O; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France., Vernerey D; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France., Jacoulet P; Department of Pneumology, University Hospital of Besançon, Besançon, France., Meurisse A; Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France., Laheurte C; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France., Almotlak H; Department of Medical Oncology, University Hospital of Besançon, Besançon, France., Jacquin M; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France., Kaulek V; Department of Pneumology, University Hospital of Besançon, Besançon, France., Boullerot L; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France., Malfroy M; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France., Orillard E; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.; Department of Pneumology, University Hospital of Besançon, Besançon, France., Eberst G; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; Department of Pneumology, University Hospital of Besançon, Besançon, France., Lagrange A; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France., Favier L; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France., Gainet-Brun M; Department of Pneumology, University Hospital of Besançon, Besançon, France., Doucet L; Department of Medical Oncology, AP-HP Hôpital Saint Louis, Paris, France., Teixeira L; Department of Medical Oncology, AP-HP Hôpital Saint Louis, Paris, France., Ghrieb Z; INSERM CIC 1427, Centre d'Investigations Cliniques, Université de Paris Cité, AP-HP Hôpital Saint-Louis, Paris, France., Clairet AL; Department of Pharmacy, University Hospital of Besançon, Besançon, France., Guillaume Y; Department of Pharmacy, University Hospital of Besançon, Besançon, France., Kroemer M; Department of Pharmacy, University Hospital of Besançon, Besançon, France., Hocquet D; Hygiène Hospitalière, Centre Hospitalier Universitaire, Besançon, France., Moltenis M; Vigilance Unit, Department of Clinical Research and Innovation, University Hospital of Besançon, Besançon, France., Limat S; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; Department of Pharmacy, University Hospital of Besançon, Besançon, France., Quoix E; Department of Pneumology, Strasbourg University Hospital, Strasbourg, France., Mascaux C; University of Strasbourg, Inserm UMR_S1113, IRFAC, Laboratory Streinth (Stress rEsponse and iNnovative therapy against cancer), ITI InnoVec, Strasbourg, France., Debieuvre D; GHRMSA, Mulhouse, France., Fagnoni-Legat C; Department of Pharmacy, University Hospital of Besançon, Besançon, France., Borg C; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France., Westeel V; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.; Department of Pneumology, University Hospital of Besançon, Besançon, France.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 10; Vol. 41 (2), pp. 373-384. Date of Electronic Publication: 2022 Sep 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.